Jump to content

Aripiprazole: Difference between revisions

From Wikipedia, the free encyclopedia
Content deleted Content added
No edit summary
No edit summary
Line 1: Line 1:
'''Aripiprazole''' (brand name: '''Abilify''') is one of the newer [[antipsychotic]] medications to hit the market. Like the other [[atypical antipsychotic|atypical antipsychotics]], it has activity at [[dopamine]] and [[serotonin]] receptors in the brain. It is used in the treatment of [[schizophrenia]].
'''Aripiprazole''' (brand name: '''[[Abilify]]''') is one of the newer [[antipsychotic]] medications to hit the market. Like the other [[atypical antipsychotic|atypical antipsychotics]], it has activity at [[dopamine]] and [[serotonin]] receptors in the brain. It is used in the treatment of [[schizophrenia]].


A warning has gone out recently because of this drug's name. The '-azole' ending of this drug name makes this drug sound like it is one of the [[proton pump inhibitors]] (such as [[omeprazole]], [[pantoprazole]], [[lansoprazole]]) which are used in treating [[peptic ulcer disease]]. However, aripiprazole and these drugs are in an entirely different class of drugs altogether and confusing the two can lead to some unnecessary side effects.
A warning has gone out recently because of this drug's name. The '-azole' ending of this drug name makes this drug sound like it is one of the [[proton pump inhibitors]] (such as [[omeprazole]], [[pantoprazole]], [[lansoprazole]]) which are used in treating [[peptic ulcer disease]]. However, aripiprazole and these drugs are in an entirely different class of drugs altogether and confusing the two can lead to some unnecessary side effects.

Revision as of 06:05, 19 September 2003

Aripiprazole (brand name: Abilify) is one of the newer antipsychotic medications to hit the market. Like the other atypical antipsychotics, it has activity at dopamine and serotonin receptors in the brain. It is used in the treatment of schizophrenia.

A warning has gone out recently because of this drug's name. The '-azole' ending of this drug name makes this drug sound like it is one of the proton pump inhibitors (such as omeprazole, pantoprazole, lansoprazole) which are used in treating peptic ulcer disease. However, aripiprazole and these drugs are in an entirely different class of drugs altogether and confusing the two can lead to some unnecessary side effects.

Aripiprazole was develeloped by Otsuka Pharmaceutical Co., Ltd and is manufactured by the Bristol Myers Squibb Company (NYSE: BMY).

Aripiprazole was approved by the FDA on November 15, 2002.


This article is a stub. You can help Wikipedia by fixing it.